Drug Use Investigation for Toviaz
Latest Information Update: 07 Nov 2021
Price :
$35 *
At a glance
- Drugs Fesoterodine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 10 Aug 2016 Status changed from active, no longer recruiting to completed.
- 12 Jul 2016 Planned End Date changed from 1 Jun 2016 to 1 Jul 2016.
- 13 Jun 2016 Planned End Date changed from 1 May 2016 to 1 Jun 2016.